NN1250 (insulin degludec)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NN1250 (insulin degludec), covering 2017-01-20 to 2017-01-20. Get the full timeline:
Most recent: Clinical Trial Update: A Trial Investigating the Pharmacokinetic (Mode of Action in the Body) and Safety Profiles of NN1250 (Insulin Degludec) in Subjects With Various Degrees of Impaired Liver Function and in Subjects With Normal Liver Function [Phase 1]